Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/test-epi-composition/ and changes regularly. See the Directory of published versions
Full name:
Authorised dose form:
Legal status of supply:
Domain:
Resource status:
Product classification:
Document Details
Generated Narrative: Bundle TEST PURPOSES ONLY - melatonin
Language: en
Profile: Bundle - ePI
Final Document at 2022-02-16 13:28:17+0000 by Organization ACME industry for Bundle: identifier = http://ema.europa.eu/identifier#None; type = document; timestamp = 2023-06-27 10:09:22+0000
Document Subject
Generated Narrative: MedicinalProductDefinition mpa1ae178fa1feba2157e2ad80fb8616d6
identifier: http://ema.europa.eu/identifier
/EU/1/22/1694/001
type: Medicinal Product
domain: Human use
status: active
legalStatusOfSupply: Medicinal product subject to medical prescription
name
productName: Melatonin Neurim 2 mg prolonged-release tablets
type: Full name
part
part: nan
type: Invented name part
part
part: nan
type: Scientific name part
part
part: nan
type: Strength part
part
part: nan
type: Pharmaceutical dose form part
Usages
Country Jurisdiction Language EU EU en
Document Content
Generated Narrative: Composition composition-en-a1ae178fa1feba2157e2ad80fb8616d6
Language: en
Profile: Composition (ePI)
identifier: http://ema.europa.eu/identifier
/EU/1/22/1694/001
status: Final
type: Package Leaflet
category: Raw
date: 2022-02-16 13:28:17+0000
author: Organization ACME industry
title: TEST PURPOSES ONLY - melatonin
Mode | Time |
Official | 2022-02-16 13:28:17+0000 |
What is in this leaflet:
The active substance of Melatonin Neurim, melatonin, belongs to a natural group of hormones produced by the body.
Melatonin Neurim is used on its own for the short-term treatment of primary insomnia (persistent difficulty in getting to sleep or staying asleep, or poor quality of sleep) in patients aged 55 years and older. Primary means that the insomnia does not have any identified cause, including any medical, mental or environmental cause.
Do not take Melatonin Neurim
Warnings and precautions Talk to your doctor or pharmacist before taking Melatonin Neurim.
Other medicines and Melatonin Neurim Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. These medicines include:
Fluvoxamine (used for the treatment of depression and obsessive compulsive disorder), psoralens (used in the treatment of skin disorders e.g. psoriasis), cimetidine (used in the treatment of stomach problems such as ulcers), quinolones and rifampicin (used in the treatment of bacterial infections), oestrogens (used in contraceptives or hormone replacement therapy) and carbamazepine (used in the treatment of epilepsy).
Adrenergic agonists/antagonists (such as certain types of medicines used to control blood pressure by constricting blood vessels, nasal decongestants, blood pressure lowering medicines), opiate agonists/antagonists (such as medicinal products used in the treatment of drug addiction), prostaglandin inhibitors (such as nonsteroidal anti-inflammatory medicines), antidepressant medication, tryptophan and alcohol.
Benzodiazepines and non-benzodiazepine hypnotics (medicines used to induce sleep such as zaleplon, zolpidem and zopiclone)
Thioridazine (for the treatment of schizophrenia) and imipramine (for the treatment of depression).
Melatonin Neurim with food, drink and alcohol Take Melatonin Neurim after you have eaten. Do not drink alcohol before, during or after taking Melatonin Neurim, because it reduces the effectiveness of Melatonin Neurim.
Pregnancy and breast-feeding Do not take Melatonin Neurim if you are pregnant, think you may be pregnant, trying to become pregnant or breast-feeding. Ask your doctor or pharmacist for advice before taking this medicine.
Driving and using machines Melatonin Neurim may cause drowsiness. If you are affected, you should not drive or operate machinery. If you suffer from continued drowsiness, then you should consult your doctor.
Melatonin Neurim contains lactose monohydrate. Melatonin Neurim contains lactose monohydrate. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
The recommended dose is one Melatonin Neurim tablet (2 mg) taken daily by mouth, after food, 1-2 hours before bedtime. This dosage may be continued for up to thirteen weeks.
You should swallow the tablet whole. Melatonin Neurim tablets should not be crushed or cut in half.
If you take more Melatonin Neurim than you should If you have accidentally taken too much of your medicine, contact your doctor or pharmacist as soon as possible.
Taking more than the recommended daily dose may make you feel drowsy.
If you forget to take Melatonin Neurim If you forget to take your tablet, take another as soon as you remember, before going to sleep, or wait until it is time to take your next dose, then go on as before.
Do not take a double dose to make up for a forgotten dose.
If you stop taking Melatonin Neurim There are no known harmful effects if treatment is interrupted or ended early. The use of Melatonin Neurim is not known to cause any withdrawal effects after treatment completion.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you experience any of the following serious side effects, stop taking the medicine and contact your doctor immediately:-
Uncommon: (may affect up to 1 in 100 people)
Rare: (may affect up to 1 in 1000 people)
If you experience any of the following non-serious side effects contact your doctor and/or seek medical advice:-
Uncommon: (may affect up to 1 in 100 people)
Irritability, nervousness, restlessness, insomnia, abnormal dreams, nightmares, anxiety, migraine, headache, lethargy (tiredness, lack of energy), restlessness associated with increased activity, dizziness, tiredness, high blood pressure, upper abdominal pain, indigestion, mouth ulceration, dry mouth, nausea, changes in the composition of your blood which could cause yellowing of the skin or eyes, inflammation of the skin, night sweats, itching, rash, dry skin, pain in extremities, menopausal symptoms, feeling of weakness, excretion of glucose in the urine, excess proteins in the urine, abnormal liver function and weight increase.
Rare: (may affect up to 1 in 1000 people)
Shingles, high level of fatty molecules in the blood, low serum calcium levels in the blood, low sodium levels in the blood, altered mood, aggression, agitation, crying, stress symptoms, early morning awakening, increased sex drive, depressed mood, memory impairment, disturbance in attention, dreamy state, restless legs syndrome, poor quality sleep, pins and needles feeling, watery eyes, dizziness when standing or sitting, hot flushes, acid reflux, stomach disorder, blistering in the mouth, tongue ulceration, stomach upset, vomiting, abnormal bowel sounds, wind, excess saliva production, bad breath, abdominal discomfort, gastric disorder, inflammation of the stomach lining, eczema, skin rash, hand dermatitis, itchy rash, nail disorder, arthritis, muscle spasms, neck pain, night cramps, prolonged erection that might be painful, inflammation of the prostate gland, tiredness, pain, thirst, passing large volumes of urine, urinating during the night, increased liver enzymes, abnormal blood electrolytes and abnormal laboratory tests.
Frequency not known: (cannot be established from the available data)
Hypersensitivity reaction, swelling of mouth or tongue, swelling of the skin and abnormal milk secretion.
Reporting of side effects If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton (EXP). The expiry date refers to the last day of that month.
Do not store above 25 C. Store in the original package in order to protect from light.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
What Melatonin Neurim contains
What Melatonin Neurim looks like and contents of the pack Melatonin Neurim 2 mg prolonged-release tablets are available as white to off-white round bi-convex shaped tablets. Each carton of tablets contains one blister strip of 7, 20 or 21 tablets, or alternatively in a carton containing two blister strips of 15 tablets each (30 tablet pack). Not all pack sizes may be marketed. Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder:
RAD Neurim Pharmaceuticals EEC SARL 4 rue de Marivaux 75002 Paris France e-mail: regulatory@neurim.com
Manufacturer:
Sites responsible for Batch Release in the EEA:-
Iberfar Ind stria Farmac utica S.A. Estrada Consiglieri Pedroso Queluz De Baixo Barcarena 2734-Portugal
Rovi Pharma Industrial Services, S.A. V a Complutense, Alcal de Henares Madrid, 28Spain
This leaflet was last revised in {month/YYYY}.
Other sources of information
Detailed information on this medicine is available on the European Medicines Agency web site:
Entry 1 - fullUrl = Composition/composition-en-a1ae178fa1feba2157e2ad80fb8616d6
Resource Composition:
Generated Narrative: Composition composition-en-a1ae178fa1feba2157e2ad80fb8616d6
Language: en
Profile: Composition (ePI)
identifier:
http://ema.europa.eu/identifier
/EU/1/22/1694/001status: Final
type: Package Leaflet
category: Raw
date: 2022-02-16 13:28:17+0000
author: Organization ACME industry
title: TEST PURPOSES ONLY - melatonin
Attesters
Mode Time Official 2022-02-16 13:28:17+0000
Entry 2 - fullUrl = MedicinalProductDefinition/mpa1ae178fa1feba2157e2ad80fb8616d6
Resource MedicinalProductDefinition:
Generated Narrative: MedicinalProductDefinition mpa1ae178fa1feba2157e2ad80fb8616d6
identifier:
http://ema.europa.eu/identifier
/EU/1/22/1694/001type: Medicinal Product
domain: Human use
status: active
legalStatusOfSupply: Medicinal product subject to medical prescription
name
productName: Melatonin Neurim 2 mg prolonged-release tablets
type: Full name
part
part: nan
type: Invented name part
part
part: nan
type: Scientific name part
part
part: nan
type: Strength part
part
part: nan
type: Pharmaceutical dose form part
Usages
Country Jurisdiction Language EU EU en